The industry continues to see rapid growth within biologics, bringing new and improved medicines to patients. As these biologics progress through the clinic and into the market it’s important to understand your products’ characteristics and formulation aiding in successful technology transfers and lifecycle management transitions into new presentations.
This webinar covers the key considerations for formulation screening of therapeutic proteins with a focus on maintaining protein stability and avoiding aggregation. This is followed by a discussion showing how consistency, planning, and communication are essential elements for a successful biologic drug product technical transfer. The session ends with a presentation of current innovations in injection delivery systems, an update on the demand for large-volume injectors, as well as usability insights on patient delivery methods.